AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
3.470
-0.080 (-2.25%)
At close: Oct 13, 2025, 4:00 PM EDT
3.450
-0.020 (-0.58%)
After-hours: Oct 13, 2025, 4:17 PM EDT
AC Immune Market Cap
AC Immune has a market cap or net worth of $343.33 million as of October 13, 2025. Its market cap has decreased by -6.53% in one year.
Market Cap
343.33M
Enterprise Value
189.66M
1-Year Change
-6.53%
Ranking
Category
Stock Price
$3.47
Market Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $343.33M, a decrease of -60.42%. That is a compound annual growth rate of -9.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 356.50M | 32.23% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
| Sep 23, 2016 | 867.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |